Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis.

Mechie NC, Röver C, Cameron S, Amanzada A

Open source

DOI
10.4254/wjh.v6.i10.759
Published
2014 Oct 27
Container
World journal of hepatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4254/wjh.v6.i10.759,
  title = {Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis.},
  author = {Mechie NC and Röver C and Cameron S and Amanzada A},
  year = {2014},
  journal = {World journal of hepatology},
  doi = {10.4254/wjh.v6.i10.759},
  url = {https://doi.org/10.4254/wjh.v6.i10.759}
}

RIS

TY  - JOUR
TI  - Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis.
AU  - Mechie NC
AU  - Röver C
AU  - Cameron S
AU  - Amanzada A
PY  - 2014
JO  - World journal of hepatology
DO  - 10.4254/wjh.v6.i10.759
UR  - https://doi.org/10.4254/wjh.v6.i10.759
ER  - 

APA

NC, M., C, R., S, C., & A, A. (2014). Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis.. World journal of hepatology. https://doi.org/10.4254/wjh.v6.i10.759

Source records